跳至主要内容
临床试验/ISRCTN68592648
ISRCTN68592648已完成未知

A dose-ranging study of paraxanthine ingestion on cognition, executive function, and psychomotor vigilance

Ingenious Ingredients L.P.0 个研究点目标入组 15 人开始时间: 2021年9月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
15

研究概览

简要总结

2021 Results article in https://doi.org/10.3390/nu13124478 (added 05/01/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • All subjects were healthy and free from known:
  • 1. Cognitive deficit conditions
  • 2. Wheat flour allergies
  • 3. Sleep disorders
  • 4. Cardiovascular, metabolic, or pulmonary diseases
  • 5. History of hypertension, migraine headaches, cardiac arrhythmias, or anxiety
  • 6. Gastrointestinal reflux disease or ulcers

排除标准

  • Subjects who were taking prescription medications in the month prior to the initiation of the study and/or were told by a physician to abstain or restrict caffeine and/or stimulant intake

研究者

发起方
Ingenious Ingredients L.P.

相似试验